nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-88B14659·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.2 Clinical medicine·Subfield: Genetics·Basis: Full text·Type: Prediction or prognostic modeling

Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.

Rossi et al.Rossi, Sportelli, Kikidis et al.·2026·Nature genetics·10.1038/s41588-026-02646-3 ↗

Primary claim

Applying this framework to Psychiatric Genomics Consortium wave 3 genotypes identified 766 genes associated with schizophrenia

Tentative · association design lacks independent schizophrenia replication and inherits evaluation-dependent gene selection
In brief

Coexpression-informed trans models broaden schizophrenia TWAS coverage, but evaluation-cohort-dependent filtering makes the reported predictive gains materially uncertain.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

Most genetic variants associated with complex heritability phenotypes lie in non-coding regions and are thought to influence disease risk by regulating gene expression. However, most transcriptome-wide association approaches primarily model local (cis) genetic effects, leaving much of gene regulation unexplained. Here, we show that incorporating distal (trans) regulatory effects improves the prediction of gene expression and the identification of disease-associated genes. Using RNA sequencing data from six human post-mortem brain regions, we developed INGENE and MODULE, two models capturing the combined influence of candidate trans-acting variants within gene coexpression networks. Integrating these models with conventional cis-based predictors improved gene expression imputation (maximum likelihood estimation, α = 0.05) for 18,744 genes across regions. Applying this framework to Psychiatric Genomics Consortium wave 3 genotypes identified 766 genes associated with schizophrenia (PFDR < 0.01), including 641 not previously reported by transcriptome-wide analyses. These findings highlight the contribution of distal regulatory mechanisms and gene network interactions to schizophrenia risk.

Key Claims

Primary finding · Tentative

Applying this framework to Psychiatric Genomics Consortium wave 3 genotypes identified 766 genes associated with schizophrenia

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

association design lacks independent schizophrenia replication and inherits evaluation-dependent gene selection

Abstract; Results, “coTWAS identifies trait associations in PGC3 cohorts”
Quote verified
Secondary · Tentative

Integrating these models with conventional cis-based predictors improved gene expression imputation for 18,744 genes across regions

the pooled count uses evaluation-dependent filtering and exceeds the per-region cis–trans enhancement counts

Abstract; Results, Figure 4a
Secondary · Tentative

incorporating distal (trans) regulatory effects improves the prediction of gene expression and the identification of disease-associated genes

coverage increases, but trans models have lower external per-gene accuracy and disease associations remain unvalidated

Abstract
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Broad trans-aware TWAS methodological extension

INGENE and MODULE provide distinct coexpression-informed routes to trans prediction and are integrated with CIS and EpiXcan. The study also compares its approach with BGW-TWAS and MOSTWAS in DLPFC.

↳ Introduction; Results, “Evaluation of cis and trans model training performance”

#methodological rigour

Multi-cohort predictive evaluation design

Models are examined across LIBD, GTEx, and CMC brain datasets, and the combined predictor is evaluated in CMC after fitting in GTEx. The results transparently show that cis models retain higher per-gene external adjusted R².

↳ Results, Figures 3 and 4c

#application pathway

Large schizophrenia association application

The integrated framework is applied across 62 PGC3 cohorts comprising 102,613 individuals, with conditional analysis and leave-site-out consistency assessment. This creates a substantial hypothesis-generation resource for psychiatric genetics.

↳ Results, “coTWAS identifies trait associations in PGC3 cohorts”; Table 2; Supplementary Figure 18

Limitations

#methodological rigour

Independent testing is materially compromised

Trans genes are retained using agreement with models trained in GTEx or CMC before those cohorts are described as independent evaluation datasets. This asymmetric, evaluation-cohort-dependent selection can inflate the reported coverage of trans models.

↳ Methods, “Cross-dataset training of INGENE and MODULE”; Results, “Evaluation of cis and trans models on a testing dataset”

#reporting

Headline improvement count lacks precision

The abstract associates improved imputation with 18,744 genes, whereas Figure 4a reports only 847–1,362 genes per region for which the cis–trans model was best. Uncorrected per-gene selection at α=0.05 further complicates interpretation of the pooled count.

↳ Abstract; Methods, “ANOVA analysis in GTEx”; Results, Figure 4a

#positioning

Mechanistic claims exceed association design

The paper acknowledges that imputed-expression associations do not establish causality and that bulk tissue obscures cell types, yet concludes that network interactions contribute substantially to schizophrenia risk. The 641 newly reported associations also lack PGC-independent or functional validation.

↳ Discussion, limitations paragraph and final paragraph; Results, Figure 6

Does this match your read? Add your assessment ↓

Nabu Commentary

The paper makes a meaningful methodological contribution by adding two coexpression-informed trans predictors and applying the integrated framework at PGC3 scale. Its strongest execution features are the use of multiple brain cohorts, relevant cis and cis–trans comparators, and transparent reporting that cis models have higher external per-gene accuracy. The central uncertainty is created by cross-dataset filtering that uses GTEx- and CMC-trained trans models before those cohorts are presented as independent tests. Headline coverage, novelty, and mechanistic claims therefore require narrower wording and genuinely independent validation.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.0±0.2

Contribution
3.6

The study adds two coexpression-informed trans predictors, compares them with established cis and cis–trans methods, and applies the integrated framework to a large schizophrenia dataset. The advance is meaningful, although it primarily expands predictive coverage rather than improving per-gene trans-model accuracy.

Introduction; Results, Figures 2–4 and 6

“both trans models substantially increased the number of predictable genes relative to cis-only approaches”

Methodological Rigour
2.5

The analysis includes multiple cohorts, cross-validation, several baselines, and CMC evaluation of the combined model. However, trans-gene retention uses models trained in GTEx or CMC before those cohorts are described as independent tests, and no network-specific ablation isolates the contribution of coexpression structure.

Methods, “Cross-dataset training of INGENE and MODULE”; Results, Figures 3–4

“Genes were retained if at least one cross-dataset correlation was positive”

Reporting
3.3

The manuscript follows a coherent progression from model construction through validation and coTWAS application, and it reports the lower external per-gene accuracy of trans predictors. The abstract’s claim of improved imputation for 18,744 genes is broader than Figure 4a’s much smaller per-region counts for which cis–trans was the best model.

Abstract; Results, “Combination of cis and trans scores enhances gene expression prediction in GTEx”; Figure 4a

“18,744 genes were significantly predicted by the integration of all models”

Positioning
3.3

The paper engages with cis-TWAS and prior cis–trans frameworks and identifies limitations involving sample size, bulk tissue, ancestry, sex, and noncausal interpretation. The final mechanistic language and cell-type discussion do not fully preserve those limits.

Discussion, limitations paragraph and final paragraph

“associations reflect genetically predicted expression and do not establish causality”

Lower confidence on Methodological Rigour — domain match limited.

Reliability

Caveats4 of 4 checks


Results checkNoted
  • Integrating these models with conventional cis-based predictors improved gene expression imputation for 18,744 genes across regions: "Integrating these models with conventional cis-based predictors improved gene expression imputation (maximum likelihood estimation, α = 0.05) for 18,744 genes across regions." (Abstract) vs "Best-fitting model counts per region: amygdala (trans, 7,169; cis, 2,717; cis–trans, 847), CN (trans, 5,763; cis, 3,674; cis–trans, 889), dACC (trans, 8,393; cis, 2,822; cis–trans, 949), DLPFC (trans, 8,148; cis, 4,475; cis–trans, 1,362), HP (trans, 5,790; cis, 2,654; cis–trans, 881), sACC (trans, 8,521; cis, 3,443; cis–trans, 1,232)." (Figure 4a caption). The cis–trans best-model counts sum to 847 + 889 + 949 + 1,362 + 881 + 1,232 = 6,160 gene–region pairs, so they cannot establish improvement from combining cis and trans predictors for 18,744 distinct genes. → Not supported by the paper's own data
Reporting and transparencyNoted

The ancestry-exclusion sentence conflicts with the stated European-ancestry inclusion criterion, but the supplied text cannot establish which threshold was implemented or recalculate any affected result.

Ethics approval: declared

Reference IntegrityClean

122 references in manuscript 118 of 118 checkable references found in an index 4 have no canonical index record — counted, but not index-checkable 4 references confirmed by manual review

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Mental health · Schizophrenia
Type of advanceMethodological
Route to useSuggested
AdvanceExtends
BeneficiariesLarge
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessValidated
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim of 766 schizophrenia-associated genes was tested in 102,613 individuals across 62 independent PGC3 cohorts, with models validated in external GTEx and CMC datasets and leave-site-out replication.

From the paper
“this framework complements traditional polygenic risk scores while providing gene-level interpretation of genetic liability”

The discussion names a possible use in interpreting genetic liability and complementing risk prediction, but names no profession, organisation or setting that would act on the findings.

Pathway

Psychiatric geneticists and drug-discovery researchers would use the identified genes, especially the 641 novel trans-driven ones, to prioritise mechanisms and targets for schizophrenia.

Barrier

The associations rely on genetically predicted expression from bulk post-mortem tissue and do not establish causality, so novel trans-regulated genes require experimental and independent validation.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Genome-wide meta-analysis of quantitatively measured generalized anxiety symptoms in individuals of European ancestry

    Skelton, Mitchell, Assary, et al. · 2026 · Clinical medicine

    Primary claim

    We identified 80 independent genome-wide significant variants within 74 loci, 39 of which were newly associated with anxiety.

    Well-supported
    Evidence Score
    4.0±0.2
    Reliability
    Caveats
  2. Shared proteomic landscape between arteriosclerosis and cardiovascular endpoints: a Mendelian randomization and observational study integrating AlphaFold3 for structural prediction

    Huang, Meena, Achtari, et al. · 2026 · Clinical medicine

    Primary claim

    We prioritized 10 proteins potentially causally associated with both the arteriosclerotic/atherosclerotic markers and cardiovascular events.

    Supported
    Evidence Score
    3.3±0.2
    Reliability
    Caveats
  3. GWAS of extended prescription analgesic use identifies genetic loci in chronic pain

    Harlow, Uzochukwu, Fernando, et al. · 2026 · Clinical medicine

    Primary claim

    Integrating these genetic associations with functional data identifies potential mechanisms involved in chronic pain, implicating oligodendrocyte differentiation, neuronal guidance, endolysosomal function and post-synaptic endosome recycling.

    Tentative
    Evidence Score
    3.4±0.2
    Reliability
    Caveats

How the rubric works →